Fortune Brands Innovations (FBIN) director receives 711-share equity grant instead of cash

Rhea-AI Filing Summary

Finan Irial reported acquisition or exercise transactions in this Form 4 filing.

Fortune Brands Innovations director Irial Finan received 711 shares of common stock on June 29, 2026 as a grant in lieu of cash fees. The shares were credited to his deferral account under the company’s Deferred Compensation Plan at a price of $0.00 per share. Following this award, Finan directly holds 28,365 shares, including 19,728 shares whose receipt is deferred until the January after he leaves the Board.

Insights

Equity compensation analyst

Routine director fee deferral into stock, small relative to holdings.

Director Irial Finan acquired 711 shares of Fortune Brands Innovations common stock via a grant credited to his deferral account, instead of taking cash fees. The grant carried a stated price of $0.00, consistent with non-cash equity compensation.

This brings his direct holdings to 28,365 shares, including 19,728 shares deferred until the January after he leaves the Board. The scale is modest, there are no open-market trades, and no derivative positions are reported, so this appears to be routine governance-related compensation rather than a directional signal.

Insider Trade Summary

Net Buyer: 711 shares

Net Buy 1 txn

Insider Finan Irial

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, Par Value $0.01	711	$0.00	$0.00

Holdings After Transaction: Common Stock, Par Value $0.01 — 28,365 shares (Direct)

Footnotes (2)

1. F1. Reflects shares credited to Mr. Finan's deferral account in lieu of cash compensation earned for services as a Director pursuant to the issuer's Deferred Compensation Plan.
2. F2. Includes 19,728 shares of common stock, receipt of which was deferred until the January following the calendar year in which Mr. Finan ceases to be a member of the Board of Directors.

Key Figures

Shares granted: 711 shares Grant price: $0.00 per share Total shares after transaction: 28,365 shares +1 more

4 metrics

Shares granted 711 shares Non-derivative stock award on June 29, 2026

Grant price $0.00 per share Equity compensation credited to deferral account

Total shares after transaction 28,365 shares Direct holdings following the June 29, 2026 award

Deferred shares 19,728 shares Receivable in January after Finan leaves the Board

Key Terms

Deferred Compensation Plan, deferral account, non-derivative, Common Stock, Par Value $0.01

4 terms

Deferred Compensation Plan financial

"pursuant to the issuer's Deferred Compensation Plan"

A deferred compensation plan is an arrangement where an employer agrees to pay part of an employee’s pay or bonus at a later date instead of immediately, often to reduce current tax bills or to tie rewards to long-term performance. For investors it matters because these promises create future cash obligations and influence executive incentives and retention; they can affect a company’s reported liabilities, cash flow planning and the risk profile if the business faces financial trouble.

deferral account financial

"Reflects shares credited to Mr. Finan's deferral account in lieu of cash"

non-derivative financial

"transaction_type": "non-derivative""

Common Stock, Par Value $0.01 financial

"security_title": "Common Stock, Par Value $0.01""

FAQ

What did Irial Finan acquire in the latest FBIN Form 4 filing?

Irial Finan received 711 shares of Fortune Brands Innovations common stock as a grant on June 29, 2026. The shares were credited to his director deferral account in lieu of cash compensation under the company’s Deferred Compensation Plan.

Was cash paid for the 711 Fortune Brands Innovations shares granted to Irial Finan?

No cash was paid for these shares; the transaction price was reported as $0.00 per share. The award represents equity compensation, with shares credited to Finan’s deferral account instead of paying him regular director cash fees.

How many Fortune Brands Innovations shares does Irial Finan hold after this transaction?

After the grant, Irial Finan directly holds 28,365 shares of Fortune Brands Innovations common stock. This total includes previously accrued and newly credited shares in his deferral arrangements as a member of the Board of Directors.

What portion of Irial Finan’s FBIN shares are deferred until after Board service?

Of Finan’s holdings, 19,728 shares are deferred until the January following the calendar year when he ceases to be a Board member. These deferred shares reflect prior elections to postpone receipt of equity compensation as a director.

Is Irial Finan’s 711-share FBIN award an open-market purchase or a compensation grant?

It is a compensation grant, not an open-market purchase. The filing classifies it as a grant or award acquisition, with shares credited at zero price under the Deferred Compensation Plan rather than being bought on the open market.

Does the Form 4 for Irial Finan report any sales of Fortune Brands Innovations stock?

The Form 4 reports no sales of Fortune Brands Innovations stock by Irial Finan. It shows only a single non-derivative acquisition of 711 shares as an equity grant, with no dispositions or derivative transactions listed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/01/2026 - 04:33 PM Accepted by SEC EDGAR 07/01/2026 - 04:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Finan Irial

(Last) (First) (Middle)

FORTUNE BRANDS INNOVATIONS, INC.

1 HORIZON WAY, BUILDING N

(Street)

DEERFIELD ILLINOIS 60015

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Fortune Brands Innovations, Inc. [ FBIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, Par Value $0.01	06/29/2026		A(1)		711	A	$0	28,365(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares credited to Mr. Finan's deferral account in lieu of cash compensation earned for services as a Director pursuant to the issuer's Deferred Compensation Plan.

2. Includes 19,728 shares of common stock, receipt of which was deferred until the January following the calendar year in which Mr. Finan ceases to be a member of the Board of Directors.

	/s/ Angela M. Pla, Attorney-in-Fact for Irial Finan	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)